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Background
Common Variable Immunodeficiency (CVID) is character-
ized by hypogammaglobulinaemia and impaired specific
antibody production, resulting in increased susceptibility
to infections, mainly of the respiratory tract. In an attempt
to minimize the recurrent episodes of infections, some
studies have recommended immunization with inactivated
pathogens or subunits, however, experience with vaccine
administration in immunodeficient patients is limited.
Methods
Therefore, we evaluated the kinetics of B cell subtypes
and specific antibody production before and 30, 90 and
180 days post Influenza seasonal and Influenza H1N1
vaccination in 35 CVID patients followed at the Division
of Clinical Immunology and Allergy of University of São
Paulo Medical School and 16 controls. In addition, we
assessed the possible beneficial effect of vaccination in
CVID patients through application of a symptoms score
during a period of one year before and one year after
immunization.
Results
Interestingly, after vaccination, patients presented a signifi-
cant reduction on the symptoms score, however they did
not produce H1N1 and influenza specific antibodies
revealing low seroconversion and seroprotection rates
when compared to controls. The analysis of B cell kinetics
in cell cultures stimulated with Influenza lysate and
hemagglutinin peptide following immunization demon-
strated a premature expression of switched memory B cell
and plasmablasts at 30 days post vaccination which was
not maintained for 180 days as observed in controls. Com-
pared to controls, high frequency upon stimulation at 180
days post vaccination was maintained only by marginal
zone B cells. Plasmablasts frequency at any time point is
strikingly lower than in controls.
Conclusions
Despite the defect on differentiation and maintenance of
memory and plasmablasts with consequent low secretion
of specific antibodies, we conclude that CVID B cell sub-
populations were capable to recognize and proliferate
with Influenza peptides stimulation. It is possible that
composing with T cell activation and, marginal zone B
cells could be battling to prolong humoral response while
linking innate and adaptive immune system reflected by
the considerable clinical improvement observed after
vaccination.
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